Primary signet-ring cell/histiocytoid carcinoma of the eyelid: a clinicopathologic study of 5 cases and review of the literature.
Requena L, Prieto VG, Requena C, Sarasa JL, Manzano R, Seco M, Rütten A, Kazakov DV, Cerroni L, Kutzner H.
Am J Surg Pathol. 2011 Mar;35(3):378-91. doi: 10.1097/PAS.0b013e318209cac7.
Primary Adnexal Signet-Ring Cell/Histiocytoid Carcinoma.
Stewart S, Houghton J, Kamalarajah S, Curragh D.
Ophthalmic Plast Reconstr Surg. 2021 Jul-Aug 01;37(4):e134-e136. doi: 10.1097/IOP.0000000000001909.
Primary signet ring cell carcinoma of the eyelid: report of a case demonstrating further analogy to lobular carcinoma of the breast with a literature review.
Langel DJ, Yeatts RP, White WL.
Am J Dermatopathol. 2001 Oct;23(5):444-9. doi: 10.1097/00000372-200110000-00010.
Signet ring cell carcinoma of the eccrine sweat glands in the eyelid.
Wollensak G, Witschel H, Böhm N.
Ophthalmology. 1996 Nov;103(11):1788-93. doi: 10.1016/s0161-6420(96)30426-0.
A case of primary signet-ring cell/histiocytoid carcinoma of the eyelid: immunohistochemical comparison with the normal sweat gland and review of the literature.
Iwaya M, Uehara T, Yoshizawa A, Kobayashi Y, Momose M, Honda T, Ota H.
Am J Dermatopathol. 2012 Dec;34(8):e139-45. doi: 10.1097/DAD.0b013e3182590ec1.
Signet-ring cell/histiocytoid carcinoma of the eyelid: a case report and review of the literature.
Tanboon J, Uiprasertkul M, Luemsamran P.
Am J Dermatopathol. 2013 Feb;35(1):e1-5. doi: 10.1097/DAD.0b013e318264991c.
Sclerosing Signet Ring Cell Carcinoma of the Lacrimal Gland: A Potentially New Primary Entity.
Jakobiec FA, Reshef ER, Ma L, Selig MK, Lefebvre DR, Stagner AM.
Ocul Oncol Pathol. 2020 Aug;6(4):265-274. doi: 10.1159/000505490. Epub 2020 Feb 7.
Molecular profiling of a primary cutaneous signet-ring cell/histiocytoid carcinoma of the eyelid.
Raghavan SS, Clark M, Louie CY, Jensen KC, Dietrich B, Beadle BM, El-Sawy T, Baik F, Kunder CA, Brown RA.
J Cutan Pathol. 2020 Sep;47(9):860-864. doi: 10.1111/cup.13733. Epub 2020 Jun 15.
Effective diagnosis and surgical management of primary signet ring cell carcinoma of the eyelid.
Buset T, Vaudoisey L, De Saint Aubain N, Javadian R, Vanden Eynden X, Valyi Z, Dequanter D.
J Surg Case Rep. 2023 Jul 19;2023(7):rjad408. doi: 10.1093/jscr/rjad408. eCollection 2023 Jul.
Primary Signet Ring Cell/Histiocytoid Carcinoma of the Eyelid: Somatic Mutations in CDH1 and Other Clinically Actionable Mutations Imply Early Use of Targeted Agents.
Wang LC, Lin TC, Yeh YC, Ho HL, Tsai CC, Chou TY.
Curr Oncol. 2021 Feb 16;28(1):918-927. doi: 10.3390/curroncol28010090.
